• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

技术监管的历史能给纳米监管带来什么启示?

What does the history of technology regulation teach us about nano oversight?

机构信息

Emerging Technologies, Law & Ethics and Center for Study of Law, Science and Technology at Sandra Day O'Connor College of Law at Arizona State University, USA.

出版信息

J Law Med Ethics. 2009 Winter;37(4):724-31. doi: 10.1111/j.1748-720X.2009.00443.x.

DOI:10.1111/j.1748-720X.2009.00443.x
PMID:20122112
Abstract

As policy makers struggle to develop regulatory oversight models for nanotechnologies, there are important lessons that can be drawn from previous attempts to govern other emerging technologies. Five such lessons are the following: (1) public confidence and trust in a technology and its regulatory oversight is probably the most important factor for the commercial success of a technology; (2) regulation should avoid discriminating against particular technologies unless there is a scientifically based rationale for the disparate treatment; (3) regulatory systems need to be flexible and adaptive to rapidly changing technologies; (4) ethical and social concerns of the public about emerging technologies need to be expressly acknowledged and addressed in regulatory oversight; and (5) international harmonization of regulation may be beneficial in a rapidly globalizing world.

摘要

当政策制定者努力为纳米技术制定监管监督模式时,可以从之前管理其他新兴技术的尝试中吸取重要经验。以下是五个这样的经验教训:(1)公众对技术及其监管监督的信心和信任可能是技术商业成功的最重要因素;(2)除非有基于科学的理由来区别对待,否则监管应避免歧视特定技术;(3)监管系统需要灵活和适应快速变化的技术;(4)监管监督中需要明确承认和解决公众对新兴技术的伦理和社会关注;(5)在全球化迅速发展的世界中,国际监管协调可能是有益的。

相似文献

1
What does the history of technology regulation teach us about nano oversight?技术监管的历史能给纳米监管带来什么启示?
J Law Med Ethics. 2009 Winter;37(4):724-31. doi: 10.1111/j.1748-720X.2009.00443.x.
2
Governance of nanotechnology and nanomaterials: principles, regulation, and renegotiating the social contract.纳米技术和纳米材料的治理:原则、监管和重新协商社会契约。
J Law Med Ethics. 2009 Winter;37(4):706-23. doi: 10.1111/j.1748-720X.2009.00442.x.
3
Evaluating oversight systems for emerging technologies: a case study of genetically engineered organisms.评估新兴技术的监督系统:以基因工程生物体为例。
J Law Med Ethics. 2009 Winter;37(4):546-86. doi: 10.1111/j.1748-720X.2009.00431.x.
4
Science, ethics, and the "problems" of governing nanotechnologies.科学、伦理与纳米技术治理的“问题”。
J Law Med Ethics. 2009 Winter;37(4):749-58. doi: 10.1111/j.1748-720X.2009.00445.x.
5
Commentary: Emerging technologies oversight: research, regulation, and commercialization.述评:新兴技术监督:研究、监管和商业化。
J Law Med Ethics. 2009 Winter;37(4):587-93. doi: 10.1111/j.1748-720X.2009.00432.x.
6
Transnational models for regulation of nanotechnology.纳米技术监管的跨国模式。
J Law Med Ethics. 2006 Winter;34(4):714-25. doi: 10.1111/j.1748-720X.2006.00091.x.
7
Developing U.S. oversight strategies for nanobiotechnology: learning from past oversight experiences.制定美国纳米生物技术监督战略:从过去的监督经验中学习。
J Law Med Ethics. 2009 Winter;37(4):688-705. doi: 10.1111/j.1748-720X.2009.00441.x.
8
Commentary: Who's afraid of the RAC? Lessons from the oversight of controversial science.评论:谁害怕 RAC?有争议科学监督的教训。
J Law Med Ethics. 2009 Winter;37(4):685-7. doi: 10.1111/j.1748-720X.2009.00440.x.
9
Introduction: The challenge of developing oversight approaches to nanobiotechnology.引言:开发纳米生物技术监督方法面临的挑战。
J Law Med Ethics. 2009 Winter;37(4):543-5. doi: 10.1111/j.1748-720X.2009.00430.x.
10
Regulatory 'desirables' for new health technologies.新健康技术的监管“期望目标”。
Med Law Rev. 2013 Winter;21(1):1-10. doi: 10.1093/medlaw/fwt005.

引用本文的文献

1
Nanotechnology-supported THz medical imaging.纳米技术支持的太赫兹医学成像。
F1000Res. 2013 Mar 28;2:100. doi: 10.12688/f1000research.2-100.v1. eCollection 2013.
2
Introduction: the challenge of nanomedicine human subjects research: protecting participants, workers, bystanders, and the environment.引言:纳米医学人体研究的挑战:保护参与者、工作人员、旁观者和环境。
J Law Med Ethics. 2012 Winter;40(4):712-5. doi: 10.1111/j.1748-720X.2012.00702.x.